- Home
- ESQ vs MDXG Comparison
ESQ vs MDXG Comparison
Compare ESQ & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESQ | MDXG |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.0M | 1.0B |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ESQ | MDXG |
|---|---|---|
| Price | $106.23 | $3.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $120.33 | $10.00 |
| AVG Volume (30 Days) | 77.9K | ★ 757.1K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | 14.20 | ★ 14.29 |
| EPS | ★ 5.87 | 0.32 |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $28.65 | N/A |
| Revenue Next Year | $4.95 | $13.02 |
| P/E Ratio | $18.18 | ★ $11.94 |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $69.14 | $3.81 |
| 52 Week High | $119.86 | $7.99 |
Technical Indicators
Market Signals| Indicator | ESQ | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 24.37 |
| Support Level | $91.62 | N/A |
| Resistance Level | $106.32 | $7.39 |
| Average True Range (ATR) | 3.71 | 0.15 |
| MACD | 0.28 | -0.02 |
| Stochastic Oscillator | 49.56 | 11.93 |
Price Performance
Historical ComparisonAbout ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.